Search for Clinical Trial Results

Sponsored By

Leiomyoma - 52 Studies Found

Status Study
Recruiting Study Name: A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
Condition:
  • HLRCC
  • Metastatic Papillary RCC

Date: 2010-05-25
Interventions:
  • Drug: Bevacizumab Commercially
Completed Study Name: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
Condition:
  • Cutaneous Leiomyomas
  • Hereditary Leiomyomatosis and Renal Cell Cancer Date: 2009-09-03
    Interventions:
    • Biological: Botulinum toxin type A

Completed Study Name: Surgery for Intravenous Leiomyomatosis
Condition: Leiomyomatosis
Date: 2012-10-14
Recruiting Study Name: Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Condition:
  • Renal Tumor Histology
  • Cutaneous Leiomyomatosis
  • Leiomyomatosis
    Date: 1999-11-03
Completed Study Name: Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent
Condition:
  • Leiomyoma
  • Leiomyomatosis
  • Uter
    Date: 2006-08-03
    Interventions:
    • Device: Uterine fibroid embolization BeadBlock™

Completed Study Name: A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
Condition:
  • Leiomyoma
  • Uterine Fibroids
  • Uterine Neoplasms
  • Date: 2008-02-25
    Interventions:
    • Procedure: Uterine Fibroid Embolization (UFE)

Withdrawn Study Name: Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
Condition: Leiomyomas
Date: 2012-03-02
Interventions:
  • Drug: Ulipristal Acetate once

Completed Study Name: Somatic Stem Cells in Leiomyomas?
Condition: Leiomyomas
Date: 2012-05-03
Interventions: Genetic: Laparoscopic myomectomy. Following analysis and proliferation of cells isolated from removed human leiomyoma.
Completed Study Name: A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Condition: Uterine Leiomyomata
Date: 2010-02-12
Interventions:
  • Drug: Progenta 12.5 mg, admini
Next >>>